ClinicalTrials.Veeva

Menu

ACTH Stability on Whole Blood (STABACT)

U

University Hospital, Rouen

Status

Unknown

Conditions

ACTH

Treatments

Biological: Blood sampling

Study type

Interventional

Funder types

Other

Identifiers

NCT04266587
2019/0350/HP

Details and patient eligibility

About

ACTH is a peptide secreted by pituitary gland and plays an important role in regulating cortisol secretion. ACTH is determined in plasma by immunoassays using specific antibodies. Its determination is difficult because of instability in whole blood. Several factors which influence ACTH stability in blood before analysis have been identified: temperature, hemolysis, time to centrifugation and presence of protease inhibitors. Published results on ACTH whole blood stability seem contradictory.

The objective of this study is to evaluate the effect of aprotinin in 10 healthy volunteers. ACTH measurements will be performed on cobas e602 (Roche Diagnostics, Mannheim, Germany).

Enrollment

10 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adult patient aged 18 to 60,

Exclusion criteria

  • Adult with insufficient venous capital for blood collection

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 1 patient group

Healthy volunteers
Experimental group
Description:
blood sampling is done on healthy volunteers
Treatment:
Biological: Blood sampling

Trial contacts and locations

1

Loading...

Central trial contact

Francois FRAISSINET; Julien BLOT

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems